| Application no. and date | 04768997.1 (espacenet) (Federated) (European Patent Register), 20041022 | | Patent/reg. no. and date | DK/EP 1682536, 20130227 | | Publication date | 20060726 | | Priority no. and date | GB 0324791, 20031024 | | EP pub. no. and date |
EP 1682536 20060726 | | Effective date | | | Applicant/owner | SHIONOGI & CO., LTD., 1-8, Doshomachi 3-chome,
Chuo-ku
Osaka 541-0045, JP,
AstraZeneca UK Limited, 2 Kingdom Street
Greater London
London
W2 6BD, GB | | Applicant ref. no. | AST 101224 | | Inventor | OKADA, Tetsuo,
Shionogi & Company Limited, 12-4 Sagisu 5-chome
Fukushima-ku,
Osaka 553-002, JP,
HORBURY, John,
AstraZeneca, Avlon Works,
Severn Road
Hallen,
Bristol BS10 7ZE, GB,
LAFFAN, David Dermot Patrick,
AstraZeneca, Charter Way
Macclesfield,
Cheshire SK10 2NA, GB | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07D 239/42 (2006.01) , C07D 405/06 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF CALCIUMSALTET AF ROSUVASTATIN (E)-7-[4-(4-FLUORPHENYL)-6-ISOPROPYL-2-[METHYL(METHYLSULFONYL)AMINO]-PYRIMIDIN-5-YL](3R,5S)-3,5-DIHYDROXYHEPT-6-ENSYRE OG KRYSTALLINSKE MELLEMPRODUKTER DERAF | | Int. application no. | GB2004004481 | | Int. publication no. | WO2005042522 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
